213 related articles for article (PubMed ID: 4363653)
1. Alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone inhibitors of ribonucleoside diphosphate reductase.
Booth BA; Agrawal KC; Moore EC; Sartorelli AC
Cancer Res; 1974 Jun; 34(6):1308-14. PubMed ID: 4363653
[No Abstract] [Full Text] [Related]
2. Potential antitumor agents. 10. Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazones.
Mooney PD; Booth BA; Moore EC; Agrawal KC; Sartorelli AC
J Med Chem; 1974 Nov; 17(11):1145-50. PubMed ID: 4370274
[No Abstract] [Full Text] [Related]
3. Mechanism of inhibition of ribonucleoside diphosphate reductase by a-(N)-heterocyclic aldehyde thiosemicarbazones.
Sartorelli AC; Agrawal KC; Moore EC
Biochem Pharmacol; 1971 Nov; 20(11):3119-23. PubMed ID: 4332051
[No Abstract] [Full Text] [Related]
4. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
Sartorelli AC; Hilton J; Booth BA; Agrawal KC; Donnelly TE; Moore EC
Adv Biol Skin; 1972; 12():271-85. PubMed ID: 4665396
[No Abstract] [Full Text] [Related]
6. Potential antitumor agents. 6. Possible irreversible inhibitors of ribonucleoside diphosphate reductase.
Agrawal KC; Booth BA; Moore EC; Sartorelli AC
J Med Chem; 1972 Nov; 15(11):1154-8. PubMed ID: 4347551
[No Abstract] [Full Text] [Related]
7. Metabolic effects of some tumor-inhibitory pyridine carboxaldehyde thiosemicarbazones.
Booth BA; Moore EC; Sartorelli AC
Cancer Res; 1971 Mar; 31(3):228-34. PubMed ID: 5547210
[No Abstract] [Full Text] [Related]
8. Comparative studies of the antineoplastic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone and its seleno-semicarbazone, guanylhydrazone and semicarbazone analogs.
Agrawal KC; Booth BA; Michaud RL; Moore EC; Sartorelli AC
Biochem Pharmacol; 1974 Sep; 23(17):2421-9. PubMed ID: 4429575
[No Abstract] [Full Text] [Related]
9. Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones.
Cory JG; Cory AH; Rappa G; Lorico A; Liu MC; Lin TS; Sartorelli AC
Biochem Pharmacol; 1994 Jul; 48(2):335-44. PubMed ID: 8053929
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the biochemical mechanism of action of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
Sartorelli AC; Agrawal KC; Tsiftsoglou AS; Moore EC
Adv Enzyme Regul; 1976; 15():117-39. PubMed ID: 1030181
[No Abstract] [Full Text] [Related]
11. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
French FA; Blanz EJ
Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
[No Abstract] [Full Text] [Related]
12. Inhibition of deoxyribonucleotide synthesis by pyridine carboxaldehyde thiosemicarbazones.
Moore EC; Booth BA; Sartorelli AC
Cancer Res; 1971 Mar; 31(3):235-8. PubMed ID: 5102115
[No Abstract] [Full Text] [Related]
13. Potential antitumor agents. 11. Inhibitors of alkaline phosphatase, an enzyme involved in the resistance of neoplastic cells to 6-thiopurines.
Agrawal KC; Lee MH; Booth BA; Moore EC; Sartorelli AC
J Med Chem; 1974 Sep; 17(9):934-8. PubMed ID: 4370275
[No Abstract] [Full Text] [Related]
14. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
[No Abstract] [Full Text] [Related]
15. Studies on the mode of action of the copper(II)chelate of 2-keto-3-ethoxybutyraldehyde-bis(thiosemicarbazone).
Bhuyan BK; Betz T
Cancer Res; 1968 Apr; 28(4):758-63. PubMed ID: 5649064
[No Abstract] [Full Text] [Related]
16. Inhibition of ribonucleotide reductase by alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones.
Moore EC; Sartorelli AC
Pharmacol Ther; 1984; 24(3):439-47. PubMed ID: 6379688
[No Abstract] [Full Text] [Related]
17. Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity.
French FA; Blanz EJ; Shaddix SC; Brockman RW
J Med Chem; 1974 Feb; 17(2):172-81. PubMed ID: 4809253
[No Abstract] [Full Text] [Related]
18. Inhibition of the growth of sarcoma 180 ascites cells by combinations of inhibitors of nucleic acid biosynthesis and the cupric chelate of kethoxal bis-(thiosemicarbazone).
Sartorelli AC; Booth BA
Cancer Res; 1967 Sep; 27(9):1614-9. PubMed ID: 6051275
[No Abstract] [Full Text] [Related]
19. Syntheses and antitumor activities of potent inhibitors of ribonucleotide reductase: 3-amino-4-methylpyridine-2-carboxaldehyde-thiosemicarba-zone (3-AMP), 3-amino-pyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) and its water-soluble prodrugs.
Li J; Zheng LM; King I; Doyle TW; Chen SH
Curr Med Chem; 2001 Feb; 8(2):121-33. PubMed ID: 11172670
[TBL] [Abstract][Full Text] [Related]
20. Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies.
Tsimberidou AM; Alvarado Y; Giles FJ
Expert Rev Anticancer Ther; 2002 Aug; 2(4):437-48. PubMed ID: 12647987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
